Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.

Authors:

Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Vineis P, Matullo G.

Source:

Int J Cancer 2013; 133: 2004-9. doi: 10.1002/ijc.28186.

This site uses technical, analytics and third-party cookies. By continuing to browse, you accept the use of cookies.